Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease
dc.contributor.author | Gilman, Sid | en_US |
dc.contributor.author | Koeppe, Robert A. | en_US |
dc.contributor.author | Little, Roderick J. A. | en_US |
dc.contributor.author | An, Hyonggin | en_US |
dc.contributor.author | Junck, Larry | en_US |
dc.contributor.author | Giordani, Bruno | en_US |
dc.contributor.author | Persad, Carol | en_US |
dc.contributor.author | Heumann, Mary | en_US |
dc.contributor.author | Wernette, Kris | en_US |
dc.date.accessioned | 2006-04-19T13:56:47Z | |
dc.date.available | 2006-04-19T13:56:47Z | |
dc.date.issued | 2004-06 | en_US |
dc.identifier.citation | Gilman, Sid; Koeppe, Robert A.; Little, Roderick; An, Hyonggin; Junck, Larry; Giordani, Bruno; Persad, Carol; Heumann, Mary; Wernette, Kris (2004)."Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease." Annals of Neurology 55(6): 774-780. <http://hdl.handle.net/2027.42/34891> | en_US |
dc.identifier.issn | 0364-5134 | en_US |
dc.identifier.issn | 1531-8249 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34891 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15174011&dopt=citation | en_US |
dc.description.abstract | We used positron emission tomography (PET) with (+)-[ 11 C]dihydrotetrabenazine ([+]-[ 11 C]DTBZ) to examine striatal monoaminergic presynaptic terminal density in 20 patients with dementia with Lewy bodies (DLB), 25 with Alzheimer's disease (AD), and 19 normal elderly controls. Six DLB patients developed parkinsonism at least 1 year before dementia (DLB/PD) and 14 developed dementia before parkinsonism or at about the same time (DLB/AD). Striatal mean binding potential was decreased by 62 to 77% in the DLB/PD group and 45 to 67% in the DLB/AD compared to AD and control. Binding was lower in the DLB/PD group than the DLB/AD, but the differences reached only marginal significance in the caudate nucleus. No differences were found between AD and control groups though a few AD patients had binding values below the range of the controls. Subsequent neuropathological examination in one AD patient revealed both AD and DLB changes despite the absence of clinical parkinsonism. Both DLB groups had an anterior to posterior binding deficit gradient relative to controls, largest in posterior putamen, smaller in anterior putamen, smallest in caudate nucleus. The DLB/AD group showed significant binding asymmetry only in posterior putamen. We conclude that PET with (+)-[ 11 C]DTBZ differentiates DLB from AD, and decreased binding in AD may indicate subclinical DLB pathology in addition to AD pathology. Ann Neurol 2004 | en_US |
dc.format.extent | 91362 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Neuroscience, Neurology, and Psychiatry | en_US |
dc.title | Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI ; Department of Neurology, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0316 | en_US |
dc.contributor.affiliationum | Department of Radiology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Neurology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Neurology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Neurology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI | en_US |
dc.identifier.pmid | 15174011 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34891/1/20088_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/ana.20088 | en_US |
dc.identifier.source | Annals of Neurology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.